EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.
Recent Searches
As a senior manager in the Life Sciences practice, Aayush collaborates with teams on projects spanning numerous therapeutic areas, including immunology, cardiovascular, renal and metabolic (CVRM); oncology; cell and gene therapy; neurology; pain; and women’s health. He focuses on strategic planning, market entry assessments and commercial due diligence, portfolio and pipeline strategy, therapeutic and disease area strategy, GTM strategy, product launches, and brand and marketing strategy.
Aayush also advises on business development — including licensing, partnering and acquisition strategies — and brings deep experience in new product planning, forecasting, market analytics and customer insights.
He has a Bachelor in Technology from the National Institute of Technology, India.
How Aayush is shaping the future with confidence
Aayush shapes a confident, forward‑looking future by guiding therapies from idea to impact. He has led market entry assessments and commercial due diligence that steer investment toward high‑value assets. He helps design defensible portfolio strategies and launch plans that balance speed with patient safety, using demand estimation, market analytics and customer insights to anticipate demand, reduce time-to-market and improve access. By embedding measurable outcomes into every plan, he helps clients make bolder plays, and society benefit from smarter care.